These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 19557465)

  • 1. [Urine-based markers of angiogenesis in bladder cancer].
    Becker M; Tilki D; Szarvas T; Rübben H; Ergün S
    Urologe A; 2009 Jun; 48(6):609-14. PubMed ID: 19557465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Urine-based diagnostics: an update on the Kiel Tumor Bank].
    Hautmann S; Lokeshwar VB; Juenemann KP
    Urologe A; 2009 Jun; 48(6):619-24. PubMed ID: 19557467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of marker systems in the treatment of bladder cancer].
    Burger M; Vom Dorp F
    Urologe A; 2011 Mar; 50(3):303-8. PubMed ID: 21340598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Urine-based oncological diagnostic for bladder carcinoma: what is new?].
    Rübben H
    Urologe A; 2009 Jun; 48(6):597. PubMed ID: 19557463
    [No Abstract]   [Full Text] [Related]  

  • 5. [Urine markers with special regard to fluorescent in situ hybridization (FISH)].
    Lindemann-Docter K; Gaisa NT; Smeets D; Knüchel-Clarke R
    Urologe A; 2011 Mar; 50(3):297-302. PubMed ID: 21253689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Use and Promise of Urinary Markers for Urothelial Cancer.
    Tabayoyong W; Kamat AM
    Curr Urol Rep; 2018 Oct; 19(12):96. PubMed ID: 30328534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal Trial Design for Studying Urinary Markers in Bladder Cancer: A Collaborative Review.
    Lotan Y; Black PC; Caba L; Chang SS; Cookson MS; Daneshmand S; Kamat AM; McKiernan JM; Pruthi RS; Ritch CR; Steinberg GD; Svatek RS; Zwarthoff EC
    Eur Urol Oncol; 2018 Aug; 1(3):223-230. PubMed ID: 31102625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine detection of survivin and diagnosis of bladder cancer.
    Smith SD; Wheeler MA; Plescia J; Colberg JW; Weiss RM; Altieri DC
    JAMA; 2001 Jan; 285(3):324-8. PubMed ID: 11176843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Panel of Urinary Diagnostic Markers for Non-Invasive Detection of Primary and Recurrent Urothelial Urinary Bladder Carcinoma.
    Soukup V; Kalousová M; Capoun O; Sobotka R; Breyl Z; Pešl M; Zima T; Hanuš T
    Urol Int; 2015; 95(1):56-64. PubMed ID: 25662337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replacing cystoscopy by urine markers in the follow-up of patients with low-risk non-muscle-invasive bladder cancer?-An International Bladder Cancer Network project.
    Schmitz-Dräger C; Bonberg N; Pesch B; Todenhöfer T; Sahin S; Behrens T; Brüning T; Schmitz-Dräger BJ
    Urol Oncol; 2016 Oct; 34(10):452-9. PubMed ID: 27381893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary markers in the everyday diagnosis of bladder cancer.
    Dal Moro F; Valotto C; Guttilla A; Zattoni F
    Urologia; 2013; 80(4):265-75. PubMed ID: 24419920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Urine marker systems for diagnosis of urothelial cancer].
    Tritschler S; Strittmatter F; Karl A; Stief C
    Urologe A; 2013 Jul; 52(7):965-9. PubMed ID: 23784678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of urine proteins in urothelial neoplasm.
    Halder S; Dey RK; Chowdhury AR; Bhattacharyya P; Chakrabarti A
    J Proteomics; 2015 Sep; 127(Pt A):185-92. PubMed ID: 25943868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Angiogenesis in bladder: prognosis indicator and therapeutic target].
    Chabannes E; Bernardini S; Wallerand H; Bittard H
    Prog Urol; 2001 Jun; 11(3):417-27. PubMed ID: 11512452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New diagnostic and prognostic tools in bladder cancer.
    Tiguert R; Fradet Y
    Curr Opin Urol; 2002 May; 12(3):239-43. PubMed ID: 11953681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary biomarkers in bladder cancer: A review of the current landscape and future directions.
    Ng K; Stenzl A; Sharma A; Vasdev N
    Urol Oncol; 2021 Jan; 39(1):41-51. PubMed ID: 32919875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Decision Making in Surveillance of Non-Muscle-Invasive Bladder Cancer: The Evolving Roles of Urinary Cytology and Molecular Markers.
    Zuiverloon TCM; de Jong FC; Theodorescu D
    Oncology (Williston Park); 2017 Dec; 31(12):855-62. PubMed ID: 29297169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic, prognostic and surveillance urinary markers in nonmuscle invasive bladder cancer: any role in clinical practice?
    Soria F; D'Andrea D; Pohar K; Shariat SF; Lotan Y
    Curr Opin Urol; 2018 Nov; 28(6):577-583. PubMed ID: 30157039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of tumor markers in urologic consultation for screening, diagnosis, and follow-up of bladder cancer].
    Lorenzo Gómez MF
    Actas Urol Esp; 2003 Feb; 27(2):110-6. PubMed ID: 12731325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A panel of angiogenic factors for early bladder cancer detection: enzyme immunoassay and Western blot.
    Eissa S; Swellam M; Labib RA; El-Zayat T; El Ahmady O
    J Urol; 2009 Mar; 181(3):1353-60. PubMed ID: 19185322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.